Literature DB >> 1860206

Altered lipid profile after Kawasaki syndrome.

J W Newburger1, J C Burns, A S Beiser, J Loscalzo.   

Abstract

BACKGROUND: Delineation of lipid values in children after Kawasaki syndrome is important because of the predilection of this disease for the coronary arteries. METHODS AND
RESULTS: We measured plasma concentrations of total cholesterol, high density lipoprotein (HDL) cholesterol, and triglycerides using enzymatic methods in 105 patients with a history of Kawasaki syndrome. Measurements were obtained during six time periods: 10 days or less, 11-31 days, 1-3 months, 3-12 months, 1-3 years, and more than 3 years. Total cholesterol was depressed in the first interval (122.0 +/- 19.8 mg/dl, mean +/- SD), but the mean values were normal in all periods after clinical recovery (overall mean, 149.0 +/- 24.0 mg/dl). High density lipoprotein cholesterol was also depressed in the first interval (15.2 +/- 9.9 mg/dl); although high density lipoprotein cholesterol increased significantly with duration since disease onset (p less than 0.001), it remained significantly lower than expected (p less than 0.001), even in the latest interval (47.2 +/- 10.9 mg/dl). Nonfasting triglyceride levels were high (162.5 +/- 63.4 mg/dl) in the first interval and then diminished steadily with time, but this relation did not achieve statistical significance. We compared adjusted lipid levels (z scores) of 46 Kawasaki patients after clinical recovery with those of their parents; patients had similar total cholesterol levels but significantly lower high density lipoprotein cholesterol levels (p = 0.021 for mothers, p = 0.001 for fathers). Mean high density lipoprotein cholesterol after clinical recovery tended to be lower in patients with persistent coronary abnormalities than in those without such lesions (p = 0.085).
CONCLUSIONS: Kawasaki syndrome is associated with important abnormalities in lipid metabolism. Continued long-term surveillance of this population is necessary to monitor lipid levels and their relation to future development of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860206     DOI: 10.1161/01.cir.84.2.625

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  35 in total

Review 1.  Update on the treatment of Kawasaki disease in childhood.

Authors:  Robert P Sundel
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

2.  Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.

Authors:  Shuang Chen; Youngho Lee; Timothy R Crother; Michael Fishbein; Wenxuan Zhang; Atilla Yilmaz; Kenichi Shimada; Danica J Schulte; Thomas J A Lehman; Prediman K Shah; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

3.  Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.

Authors:  Chao Duan; Zhong-Dong Du; Yu Wang; Li-Qun Jia
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

Review 4.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

5.  Mid-term Risk for Subclinical Atherosclerosis and Chronic Myocarditis in Children with Kawasaki Disease and Transient Coronary Abnormalities.

Authors:  Mansingh Parihar; Surjit Singh; Pandiarajan Vignesh; Anju Gupta; Manojkumar Rohit
Journal:  Pediatr Cardiol       Date:  2017-05-17       Impact factor: 1.655

6.  Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease.

Authors:  Y F Cheung; M H K Ho; S C F Tam; T C Yung
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

Review 7.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

8.  Relationship between gallbladder distension and lipid profiles in kawasaki disease.

Authors:  Ki-Won Kim; Hak Yong Kim; Jin-Kyong Chun; Byung Ho Cha; Mee Kyung Namgoong; Woocheol Kwon; Hae Yong Lee
Journal:  Korean Circ J       Date:  2010-03-24       Impact factor: 3.243

Review 9.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

10.  Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever.

Authors:  Kyung-Yil Lee; Ji-Whan Han; Ja-Hyun Hong; Hyung-Shin Lee; Joon-Sung Lee; Kyung-Tai Whang
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.